Sandbox Myopathy: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) No edit summary |
||
Line 30: | Line 30: | ||
! rowspan="3" |Physical | ! rowspan="3" |Physical | ||
Examination | Examination | ||
! colspan=" | ! colspan="4" |Diagnosis | ||
|- | |- | ||
! rowspan="2" |Age of onset | ! rowspan="2" |Age of onset | ||
Line 40: | Line 40: | ||
! rowspan="2" |Myoglobinuria | ! rowspan="2" |Myoglobinuria | ||
! rowspan="2" |Other features | ! rowspan="2" |Other features | ||
! | ! rowspan="2" |Laboratory Findings | ||
! rowspan="2" |Creatine Kinase | ! rowspan="2" |Creatine Kinase | ||
! rowspan="2" |Muscle Biopsy | ! rowspan="2" |Muscle Biopsy | ||
Line 48: | Line 48: | ||
!DIstal | !DIstal | ||
|- | |- | ||
! colspan=" | ! colspan="16" |Medications | ||
|- | |- | ||
|Corticosteroids | |Corticosteroids | ||
Line 72: | Line 72: | ||
| | | | ||
* Facial and sphincter muscles usually are spared | * Facial and sphincter muscles usually are spared | ||
| | |||
* + ACTH Stimulation test | * + ACTH Stimulation test | ||
* 24-hour urine [[cortisol]] | * 24-hour urine [[cortisol]] | ||
Line 97: | Line 97: | ||
* Tenderness | * Tenderness | ||
* Muscle aches | * Muscle aches | ||
| | |||
* '''↑↑''' liver enzymes | * '''↑↑''' liver enzymes | ||
| | | | ||
Line 127: | Line 127: | ||
* Telangiectasia | * Telangiectasia | ||
* Peripheral neuropathy | * Peripheral neuropathy | ||
| | |||
* nonspecific and are normal in many patients | * nonspecific and are normal in many patients | ||
| | | | ||
Line 136: | Line 136: | ||
* Normal | * Normal | ||
|- | |- | ||
! colspan=" | ! colspan="16" |Endocrine | ||
|- | |- | ||
|Cushing's disease | |Cushing's disease | ||
Line 169: | Line 169: | ||
* HTN | * HTN | ||
* Hyperpigmentation | * Hyperpigmentation | ||
| | |||
* + ACTH Stimulation test | * + ACTH Stimulation test | ||
* 24-hour urine [[cortisol]] | * 24-hour urine [[cortisol]] | ||
Line 203: | Line 203: | ||
* Vitiligo | * Vitiligo | ||
| | |||
* Electrolyte abnormalities | * Electrolyte abnormalities | ||
Line 233: | Line 233: | ||
| | | | ||
* Hyperpigmentation | * Hyperpigmentation | ||
| | |||
* Hypokalemia | * Hypokalemia | ||
| | | | ||
Line 262: | Line 262: | ||
* Tremor' | * Tremor' | ||
* Swelling on neck examination | * Swelling on neck examination | ||
| | |||
* Decreased TSH | * Decreased TSH | ||
| | | | ||
Line 288: | Line 288: | ||
* Myoedema | * Myoedema | ||
* Muscle pseudohypertrophy | * Muscle pseudohypertrophy | ||
| | |||
* Increased TSH | * Increased TSH | ||
| | | | ||
Line 318: | Line 318: | ||
* Tenderness | * Tenderness | ||
| | |||
* Elevation of the erythrocyte sedimentation rate | * Elevation of the erythrocyte sedimentation rate | ||
* Leukocytosis | * Leukocytosis | ||
Line 329: | Line 329: | ||
* Normal | * Normal | ||
|- | |- | ||
! colspan=" | ! colspan="16" |Inflammatory / Rheumatologic | ||
|- | |- | ||
|Dermatomyositis<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649 }}</ref> | |Dermatomyositis<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649 }}</ref> | ||
Line 354: | Line 354: | ||
* Mechanic's hands | * Mechanic's hands | ||
* Gottron's sign ( violaceous scaly eruption ) | * Gottron's sign ( violaceous scaly eruption ) | ||
| | | rowspan="2" | | ||
* '''↑↑''' ESR | * '''↑↑''' ESR | ||
* '''↑↑''' CRP | * '''↑↑''' CRP | ||
Line 399: | Line 399: | ||
| | | | ||
| | | | ||
| | |||
| | | | ||
* '''↑↑''' | * '''↑↑''' | ||
Line 426: | Line 426: | ||
| | | | ||
* Tenderness in the soft tissue anatomical location | * Tenderness in the soft tissue anatomical location | ||
| | |||
* Normal | * Normal | ||
| | | | ||
Line 451: | Line 451: | ||
| | | | ||
* Restricted shoulder motion | * Restricted shoulder motion | ||
| | |||
* '''↑ CRP''' | * '''↑ CRP''' | ||
* '''↑ ESR''' | * '''↑ ESR''' | ||
Line 461: | Line 461: | ||
* Normal | * Normal | ||
|- | |- | ||
! colspan=" | ! colspan="16" |Genetic | ||
|- | |- | ||
|Becker muscular dystrophy | |Becker muscular dystrophy | ||
Line 478: | Line 478: | ||
* Age of onset of symptoms is much delayed than duchenne | * Age of onset of symptoms is much delayed than duchenne | ||
| | | | ||
| | |||
* Decreased amount of [[dystrophin]]. | * Decreased amount of [[dystrophin]]. | ||
| | | | ||
Line 511: | Line 511: | ||
| | | | ||
* +Grower sign | * +Grower sign | ||
| | |||
* Errors in the Xp21 gene. | * Errors in the Xp21 gene. | ||
* Absence of [[dystrophin]]. | * Absence of [[dystrophin]]. | ||
Line 537: | Line 537: | ||
| | | | ||
* | * | ||
| | |||
* LMNA gene | * LMNA gene | ||
* CAV3 gene | * CAV3 gene | ||
Line 567: | Line 567: | ||
| | | | ||
| | | | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="16" |Infectious | ||
|- | |- | ||
|Lyme disease | |Lyme disease | ||
Line 594: | Line 594: | ||
* Target-like [[lesions]] | * Target-like [[lesions]] | ||
* HSM | * HSM | ||
| | |||
* Clinical diagnosis | * Clinical diagnosis | ||
* +Serology | * +Serology | ||
Line 622: | Line 622: | ||
| | | | ||
* Muscle weakness, tenderness, and swelling. | * Muscle weakness, tenderness, and swelling. | ||
| | |||
* '''↑↑''' Liver enzymes | * '''↑↑''' Liver enzymes | ||
* +PCR | * +PCR | ||
Line 652: | Line 652: | ||
* Asymmetrical flaccid paralysis | * Asymmetrical flaccid paralysis | ||
* Pharyngeal paralysis | * Pharyngeal paralysis | ||
| | |||
* Isolation from [[pharyngeal]]<nowiki/>secretions, CSF | * Isolation from [[pharyngeal]]<nowiki/>secretions, CSF | ||
* +Serology | * +Serology | ||
Line 683: | Line 683: | ||
* Followed by [[rash]] | * Followed by [[rash]] | ||
* Generalized [[lymphadenopathy]] in secondary syphilis | * Generalized [[lymphadenopathy]] in secondary syphilis | ||
| | |||
* Darkfield examinations | * Darkfield examinations | ||
* VDRL | * VDRL | ||
Line 713: | Line 713: | ||
** Muscles are painful, swollen, tender, and indurated. | ** Muscles are painful, swollen, tender, and indurated. | ||
** Depending on the site of involvement, it may mimic appendicitis (psoas muscle), septic arthritis of the hip (iliacus muscle), or epidural abscess (piriformis muscle). | ** Depending on the site of involvement, it may mimic appendicitis (psoas muscle), septic arthritis of the hip (iliacus muscle), or epidural abscess (piriformis muscle). | ||
| | |||
* Leukocytosis | * Leukocytosis | ||
* Elevated ESR | * Elevated ESR | ||
Line 723: | Line 723: | ||
* - | * - | ||
|- | |- | ||
! colspan=" | ! colspan="16" |Neurologic | ||
|- | |- | ||
|ALS | |ALS | ||
Line 737: | Line 737: | ||
| | | | ||
| | | | ||
* Both upper and lower motor neuron signs | |||
| | | | ||
| | | | ||
* Normal | |||
| | | | ||
* Nonspecific findings of chronic denervation with reinnervation | |||
| | | | ||
* Neuropathic | * Neuropathic | ||
Line 762: | Line 764: | ||
* Weakness of the involved arm | * Weakness of the involved arm | ||
* | * | ||
| | |||
* | * | ||
| | | | ||
Line 774: | Line 776: | ||
| | | | ||
* 18 -350 | * 18 -350 | ||
| | | - | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 787: | Line 789: | ||
| | | | ||
* Weakness of lower extremities followed by upper extremities | * Weakness of lower extremities followed by upper extremities | ||
| | |||
* Cytologic albumin ratio | * Cytologic albumin ratio | ||
| | | | ||
Line 797: | Line 799: | ||
|- | |- | ||
|Multiple Sclerosis | |Multiple Sclerosis | ||
| | | | ||
| | | | ||
Line 814: | Line 815: | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="16" |Neuro-muscular | ||
|- | |- | ||
|Botulisim | |Botulisim | ||
| | | | ||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |||
| | | | ||
| | | | ||
Line 825: | Line 828: | ||
| | | | ||
| | | | ||
* H/0 Food exposure and air | |||
| | | | ||
| | | | ||
Line 836: | Line 837: | ||
|Lambert-Eaton myaes | |Lambert-Eaton myaes | ||
| | | | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | | | ||
| | | | ||
Line 854: | Line 854: | ||
|Myasthenia gravis | |Myasthenia gravis | ||
| | | | ||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
| | | | ||
| | | | ||
Line 860: | Line 862: | ||
| | | | ||
| | | | ||
* Ocular | |||
* Bulbar | |||
* Limb weakness | |||
* Isolated neck, limbs and respiratory weakness | |||
| | | | ||
| | | | ||
Line 870: | Line 876: | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="16" |Paraneoplastic | ||
|- | |- | ||
| | | | ||
| | | | ||
Line 890: | Line 895: | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="16" |Metabolic | ||
|- | |- | ||
|Glycogen storage disease | |Glycogen storage disease | ||
| | | | ||
* Variable | * Variable | ||
| | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 912: | Line 916: | ||
* Hypotonia | * Hypotonia | ||
* Hepatomeagly | * Hepatomeagly | ||
| | |||
* Lactic acidosis | * Lactic acidosis | ||
Line 925: | Line 929: | ||
* Normal | * Normal | ||
|- | |- | ||
| | | | ||
| | | |
Revision as of 23:40, 4 April 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Flow chart
Objective Muscle weakness | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Malignancy Arthralgia Anemia Firbomyalgia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Generalized | Localized | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Myasthenia gravis Periodic paralysis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asymmetric | Symmetric | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cerebrovascular accidents Demyleinating disorders Atrophy Mononeuropathy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Specific pattern | Specific pattern | Proximal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hereditary neuropathy Muscular dystrophy | Myoapthy Duchenne muscular dystrophy | Motor neuron disease Peripheral neuropathy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differentiating Various Muscle Weakness
Disease | Symptoms | History | Physical
Examination |
Diagnosis | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age of onset | Muscle weakness | Fever | Muscle pain | Gait abnormality | Neuropathy | Myoglobinuria | Other features | Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | ||||
Proximal | DIstal | ||||||||||||||
Medications | |||||||||||||||
Corticosteroids |
|
+ | - | - | + | - | - | - |
|
|
|
|
- | - | - |
Statins |
|
+ | - | - | + | - | - | -/+(rhabdomyolysis) |
|
|
|
|
|
|
- |
Alcohol |
|
+ | - | - | - | + | +/- | - |
|
|
|
|
|
|
|
Endocrine | |||||||||||||||
Cushing's disease |
|
+ | - | - | - | - | - | - |
|
|
|
|
Normal |
|
Normal |
Adrenal insufficiency |
|
+ | - | - | - | - | - | - |
|
|
|
|
|
|
|
Hyperaldosteronism with myopathy |
|
+ | + | - | - | - | - | +
Rhabdomyolysis |
|
|
|
|
|
|
|
Hyperthyroidism |
|
+ | - | - | - | - | - | + |
|
|
|
|
|
|
|
Hypothyroidism |
|
+ | - | - | + | - | - | + Rhabdomyolysis |
|
|
|
|
|
|
|
Diabetic infraction |
|
+ | - | + | + | - | + | - |
|
|
|
|
|
|
|
Inflammatory / Rheumatologic | |||||||||||||||
Dermatomyositis[1] |
|
+ | - | + | + | - | - | - |
|
|
|
|
|
| |
Polymyositis[2] |
|
+ | - | + | + | - | - | - |
|
|
|
|
| ||
Inclusion body myositis[3] |
|
+ | + |
|
|||||||||||
Fibomyalgia |
|
+ |
- | - | - | - | ++ | - |
|
|
|
|
|
|
|
Polymyalgia Rheumatica[4] |
|
+ | - | + | + | - | - | - |
|
|
|
|
|
|
|
Genetic | |||||||||||||||
Becker muscular dystrophy | <13yrs | + | - | - | - | + | - | - |
|
|
|
|
|
| |
Duchenne muscular dystrophy | <13 yrs | + | - | - | - | + | - | - |
|
|
|
|
| ||
Limb-girdle muscular dystrophies | <15 yrs | + | - | - | + | + | - | - |
|
|
|
|
|
|
|
Myotonic dystrophy type 1 | + | + | - | - | + | - | - |
|
|||||||
Infectious | |||||||||||||||
Lyme disease | Variable | + | - | + | + | +/- | + | - |
|
|
|
|
|
|
|
Infulenza | Variable | - | - | + | + | + | - | + |
|
|
|
|
|
|
|
Polio | <5 yrs | + | - | - | - | + | + | - |
|
|
|
|
|
| |
Syphilis | Variable | - | - | - | - | + | + | - |
|
|
|
|
|
|
|
Pyomyositis | Variable | +/- | +/- | + | + | - | - | - |
|
|
|
|
|
|
|
Neurologic | |||||||||||||||
ALS |
|
|
|
| |||||||||||
Stroke |
|
+ | + | - | - | + | + | - |
|
|
|
|
|
|
|
GBS |
|
- | + | - | - | + | - | - |
|
|
|
|
|
|
|
Multiple Sclerosis | |||||||||||||||
Neuro-muscular | |||||||||||||||
Botulisim | - | + |
|
||||||||||||
Lambert-Eaton myaes | + | + | |||||||||||||
Myasthenia gravis | + | + |
|
||||||||||||
Paraneoplastic | |||||||||||||||
Metabolic | |||||||||||||||
Glycogen storage disease |
|
+ | - | - | - | - | - | - |
|
|
|
|
|
|
|
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Myklebust G, Gran JT (1996). "A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis". Br J Rheumatol. 35 (11): 1161–8. PMID 8948307.